OXTR and generalized anxiety disorder: Given the intricate interplay between the serotonergic and oxytocinergic systems in stress-related circuits, we hypothesized that the OXTR rs2254298 genotype moderates escitalopram treatment response in GAD, potentially through a mechanism involving OT neuroendocrine signaling and exhibiting sex-specific effects.